MATRIX CAPITAL MANAGEMENT COMPANY, LP Adaptimmune Therapeutics plc Transaction History

MATRIX CAPITAL MANAGEMENT COMPANY, LP portfolio value:

$41.89M
portfolio value

MATRIX CAPITAL MANAGEMENT COMPANY, LP quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -24.35M $1.08 38.97M
Q2 2022 share 0.00% 0 shares -14.03M $1.7 38.97M
Q1 2022 share 0.00% 0 shares -65.86M $2.06 38.97M
Q4 2021 share 0.00% 0 shares -55.34M $3.87 38.97M
Q3 2021 share 0.00% 0 shares 35.46M $5.17 38.97M
Q2 2021 share 0.00% 0 shares -40.92M $4.26 38.97M
Q1 2021 share 0.00% 0 shares -3.11M $5.31 38.97M
Q4 2020 share 0.00% 0 shares -100.94M $5.39 38.97M
Q3 2020 share 0.00% 0 shares -79.11M $7.98 38.97M
Q2 2020 share Increase +13.20% 4.54M shares 296.48M $10.01 38.97M
Q1 2020 share Increase +22.96% 6.42M shares 60.04M $2.72 34.42M
Q4 2019 share 0.00% 0 shares -8.68M $1.2 28M
Q3 2019 share 0.00% 0 shares -70.28M $1.51 28M
Q2 2019 share 0.00% 0 shares -7.84M $4.02 28M
Q1 2019 share Increase +3.13% 851K shares -35.70M $4.3 28M
Q4 2018 share Increase +33.33% 6.78M shares -120.00M $5.75 27.14M
Q3 2018 share Increase +44.58% 6.27M shares 108.93M $13.56 20.36M
Q2 2018 share Increase +1.45% 201.5K shares 11.27M $11.87 14.08M
Q1 2018 share Increase +13.66% 1.66M shares 74.30M $11.23 13.88M
Q4 2017 share Increase +1.41% 170K shares -17.05M $6.68 12.21M
Q3 2017 share Increase +38.56% 3.35M shares 59.60M $8.19 12.04M
Q2 2017 share Increase 0.00% 8.69M shares 39.02M $4.49 8.69M